8-K ·Filed Apr 6, 2026

HOLX

HOLOGIC INC
NEUTRAL
Impact 7/10
Horizonimmediate Processed5mo ago SEC0001140361-26-013235
8-K context-dependent: Items 5.02, 8.01
Actionable Insight • Neutral

The stock will likely be delisted following the closing on April 7, 2026. Traders should position accordingly as the company transitions to private ownership. The retirement of the long-tenured CEO signals a significant leadership transition coinciding with the ownership change.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+1d
HOLX ▲ 0.00% at T+1d
NEUTRAL call ✗ call lost 0.00% · α vs SPY -0.06% · entry $76.01 → $76.01
Next anchor: T+5d due 6mo ago
Entry anchored
Apr 2, 03:59 PM ET
via exchange tick
T+1d
0.00%
call 0.00% · α -0.06%
$76.01
settled 6mo ago
T+5d
—
call — · α —
—
due 6mo ago
T+20d
—
call — · α —
—
due 5mo ago
T+60d
—
call — · α —
—
due 3mo ago

Price Chart

Loading chart...

Executive Summary

Hologic CEO Stephen MacMillan announced his retirement effective upon the closing of the company's acquisition by Blackstone and TPG, following receipt of all required regulatory approvals. The go-private transaction is expected to close on April 7, 2026.

Key Facts

  • CEO Stephen MacMillan is retiring contingent upon the closing of the Blackstone/TPG acquisition
  • All regulatory approvals for the merger have been received
  • Transaction expected to close on or about April 7, 2026
  • MacMillan served as CEO since 2013 and led significant growth in revenue, EPS, and share price
  • Next CEO will be announced at closing

Financial Impact

The acquisition represents a full change in ownership structure from public to private, removing the company from public markets. The filing confirms regulatory approval but does not disclose the transaction value.

ownership structureexecutive leadershipregulatory status

Risk Factors

  • Risk that merger conditions are not satisfied despite regulatory approval
  • Potential disruption from CEO transition and go-private process
  • Uncertainty around future leadership and strategy under new ownership

Market Snapshot

Exchange
Nasdaq
Sector
X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-013235
Document: ef20069327_ex99-1.htm0001140361-26-013235
Document: 0001140361-26-013235-index-headers.html0001140361-26-013235
Document: 0001140361-26-013235-index.html0001140361-26-013235
Document: 0001140361-26-013235.txt0001140361-26-013235
5 reports for HOLX
Performance horizon
Filters
Rows
Reports for HOLX — sortable, filterable
TypeNow
Apr 17, 2026
23w ago
15-12G
NEUTRAL ★ 7/10
—awaiting T+1——
Apr 13, 2026
24w ago
EFFECT
NEUTRAL ★ 3/10
—awaiting T+1——
Apr 7, 2026
25w ago
8-K
NEUTRAL ★ 9/10
$76.01 $76.01· 0.00%▼ −2.54%—
Apr 6, 2026
25w ago
8-K
NEUTRAL ★ 7/10
$76.01 $76.01· 0.00%▼ −0.06%—
Feb 28, 2026
30w ago
Institutional Cluster
MIXED ★ 6/10
$75.45 $75.46▲ +0.01%▲ +0.93%—
Showing 5 of 5

US Market Status

Market Open — Closes in 6h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access